CANCER SYMPTOM CONTROL

癌症症状控制方案由17个参与成员组成，代表着每年414万美元的直接成本(总成本565万美元)的同行审查资金总额。在过去的两年里，它的成员负责总共100份与癌症相关的同行审查的出版物，其中29%是方案内和方案间的合作。这个项目以前被称为“姑息治疗”，致力于研究癌症对人类意识和感官体验的影响。它由对癌症及其治疗对患者生活质量的影响进行高度连锁研究的成员组成。这些研究检查了由癌症引起的疼痛、疲劳、焦虑、抑郁和睡眠碎片，以及如何最好地改善这些，以提高生活质量和对医疗护理的满意度。研究还考察了医生和患者之间沟通的效率，以及患者的种族和文化特征对疾病主观体验的影响。这项计划带来了减轻与癌症相关的身体和精神痛苦的基础和临床研究。当然，癌症患者本身是这项关于症状控制的研究的主要受益者，但他们的家人患有严重疾病。该计划的成员开发了一系列针对癌症患者的研究人员，涉及：(1)癌症疼痛综合征；(2)癌症患者的疲劳和睡眠；(3)癌症患者的生活质量。

The Cancer Symptom Control Program consists of 17 Participating Members, representing total peer-reviewed funding for $4.14 Million annual direct costs ($5.65 Million in total costs). During the last two years, its members were responsible for a total of 100 cancer-relevant, peer-reviewed publications, 29% of which were intra- and inter- programmatic collaborations. This Program, formerly called "Palliative Care", is dedicated to research on the impact of cancer on human consciousness and sensory experience. It is comprised of members who are conduct highly interlocking studies on the consequences of cancer and its treatment on the quality of life of the patient. These examine pain, fatigue, anxiety, depression and sleep fragmentation, caused by cancer and how these can best be ameliorated to improve quality of life and satisfaction with medical care. The studies also examine the efficience of communications between doctors and their patients and the effect of ethnic and cultural characteristics of the patients of the subjective experience of the disease. This Program brings to bear both basic and clinical research on mitigating the physical and mental anguish associated with cancer. Of course, the cancer patients themselves are the main beneficiaries of this research on symptom control, but their families with severe illnesses. Members of this Program have developed a series of studiers highly specific to cancer patients in terms of: (1) cancer pain syndromes; (2) fatigue and sleep in cancer patients, and; (3) quality of life in cancer patients.